We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
+3.55%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$5.08B
AUM Growth
+$1.46B
Cap. Flow
+$1.39B
Cap. Flow %
27.41%
Top 10 Hldgs %
16.41%
Holding
2,064
New
586
Increased
519
Reduced
386
Closed
568

Sector Composition

Rank Sector Weight
1 Technology 13.8%
2 Industrials 11.19%
3 Consumer Discretionary 10.32%
4 Healthcare 10.26%
5 Financials 8.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCMP
1201
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$260K 0.01%
24,808
-6,360
-20% -$64.8K
FBC
1202
DELISTED
Flagstar Bancorp, Inc. New
FBC
$260K 0.01%
+8,437
New +$249K
OXM icon
1203
Oxford Industries
OXM
$577M
$258K 0.01%
4,121
-5,964
-59% -$344K
SDRL
1204
DELISTED
Seadrill Limited Common Stock
SDRL
$258K 0.01%
2,667
+2,565
+2,515% +$403K
HLF icon
1205
Herbalife
HLF
$1.23B
$257K 0.01%
+7,200
New +$243K
CTRL
1206
DELISTED
Control4 Corporation
CTRL
$257K 0.01%
13,100
-16,132
-55% -$290K
HTH icon
1207
Hilltop Holdings
HTH
$2.29B
$254K 0.01%
9,707
-993
-9% -$26.3K
NG icon
1208
NovaGold Resources
NG
$2.6B
$254K 0.01%
+55,801
New +$240K
AFSI
1209
DELISTED
AmTrust Financial Services, Inc.
AFSI
$254K 0.01%
16,783
-246
-1% -$3.63K
HALO icon
1210
Halozyme
HALO
$9.72B
$253K 0.01%
+19,763
New +$264K
CLVS
1211
DELISTED
Clovis Oncology, Inc.
CLVS
$253K 0.01%
+2,700
New +$165K
OSPN icon
1212
OneSpan
OSPN
$562M
$252K 0.01%
17,554
-8,436
-32% -$116K
SAGE
1213
DELISTED
Sage Therapeutics
SAGE
$252K 0.01%
3,163
-3,583
-53% -$259K
CADE
1214
DELISTED
Cadence Bank
CADE
$251K ﹤0.01%
+8,237
New +$247K
CE icon
1215
Celanese
CE
$5.09B
$251K ﹤0.01%
2,649
-16,459
-86% -$1.47M
TRMK icon
1216
Trustmark
TRMK
$2.73B
$251K ﹤0.01%
+7,794
New +$250K
NXRT
1217
NexPoint Residential Trust
NXRT
$665M
$249K ﹤0.01%
+10,009
New +$250K
BDX icon
1218
Becton Dickinson
BDX
$43.1B
$248K ﹤0.01%
1,301
-8,556
-87% -$1.56M
CTMX icon
1219
CytomX Therapeutics
CTMX
$705M
$248K ﹤0.01%
+16,000
New +$241K
INGN icon
1220
Inogen
INGN
$167M
$248K ﹤0.01%
2,600
-12,828
-83% -$1.1M
NGVT icon
1221
Ingevity
NGVT
$2.55B
$248K ﹤0.01%
+4,316
New +$254K
FTD
1222
DELISTED
FTD Companies, Inc. Common Stock
FTD
$248K ﹤0.01%
+12,409
New +$239K
EGHT icon
1223
8x8 Inc
EGHT
$247M
$247K ﹤0.01%
+16,961
New +$241K
JOE icon
1224
St. Joe Company
JOE
$3.57B
$247K ﹤0.01%
+13,170
New +$233K
SBUX icon
1225
Starbucks
SBUX
$118B
$247K ﹤0.01%
+4,241
New +$256K

Similar funds

Squarepoint's Q2 2017 Portfolio in Review

As of Q2 2017, Squarepoint held 2,064 positions worth $5.08B, up 40% from $3.63B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Squarepoint deployed $1.39B of net new capital in Q2 2017, opening 586 new positions and adding to 519 existing holdings. Its largest new stake was iShares MSCI Taiwan ETF: 2,618,387 shares worth $93.6M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was State Street SPDR S&P MIDCAP 400 ETF Trust, an estimated $33M trimmed.

  • Squarepoint's largest Q2 2017 buy was iShares MSCI Taiwan ETF: 2,618,387 shares worth $93.6M.
  • Squarepoint added most to VanEck Gold Miners ETF in Q2 2017, an estimated $71.9M increase.
  • Squarepoint's biggest Q2 2017 reduction was State Street SPDR S&P MIDCAP 400 ETF Trust, cutting an estimated $33M.
  • Squarepoint fully exited iShares MSCI EAFE ETF in Q2 2017, selling an estimated $26.5M.
  • Squarepoint's ten largest holdings make up 16% of its $5.08B portfolio in Q2 2017.
  • Squarepoint opened 586 new positions and closed 568 in Q2 2017.
  • Squarepoint's portfolio value rose 40% quarter-over-quarter to $5.08B.

Based on Squarepoint's 13F filing for Q2 2017, filed 14 Aug 2017.